Michael Schreinlechner

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Clinical and translational medicine

VASA. Zeitschrift fur Gefasskrankheiten

European heart journal

Respirology (Carlton, Vic.)

Medizinische Universität Innsbruck

Medizinische Universität Innsbruck (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medizinische Universität Innsbruck

Austria

PhD Student :: Internal Medicine, Cardiology & Angiology

Education History

Medizinische Universität Innsbruck

Austria

PHD

Publications

Philip Sommer, Michael Schreinlechner, Maria Noflatscher, Clarisse Engl, Daniela Lener, Markus Theurl, Rudolf Kirchmair, Peter Marschang
Hepatocyte growth factor as indicator for subclinical atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten 53 (2) (2024)
Andreas A Boehmer, Tim Schubert, Moritz Rothe, Christoph Keim, Lilli Wiedenmann, Christian Ruckes, Lukas von Stülpnagel, Fabian Theurl, Michael Schreinlechner, Bianca C Dobre, Bernhard M Kaess, Axel Bauer, Joachim R Ehrlich
Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure. Journal of the American Heart Association (2024)
Philip Sommer, Michael Schreinlechner, Maria Noflatscher, Clarisse Engl, Daniela Lener, Markus Theurl, Rudolf Kirchmair, Peter Marschang
Hepatocyte growth factor as indicator for subclinical atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten (2024)
Johannes Holfeld, Felix Naegele, Leo Pölzl, Clemens Engler, Michael Graber, Jakob Hirsch, Sophia Schmidt, Agnes Mayr, Felix Troger, Mathias Pamminger, Markus Theurl, Michael Schreinlechner, Nikolay Sappler, Elfriede Ruttmann-Ulmer, Wolfgang Schaden, John P Cooke, Hanno Ulmer, Axel Bauer, Can Gollmann-Tepeköylü, Michael Grimm
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European heart journal 45 (29) (2024)
Johannes Holfeld, Felix Naegele, Leo Pölzl, Clemens Engler, Michael Graber, Jakob Hirsch, Sophia Schmidt, Agnes Mayr, Felix Troger, Mathias Pamminger, Markus Theurl, Michael Schreinlechner, Nikolay Sappler, Elfriede Ruttmann-Ulmer, Wolfgang Schaden, John P Cooke, Hanno Ulmer, Axel Bauer, Can Gollmann-Tepeköylü, Michael Grimm
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European heart journal (2024)
Andreas A Boehmer, Tim Schubert, Moritz Rothe, Christoph Keim, Lilli Wiedenmann, Christian Ruckes, Lukas von Stülpnagel, Fabian Theurl, Michael Schreinlechner, Bianca C Dobre, Bernhard M Kaess, Axel Bauer, Joachim R Ehrlich
Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure. Journal of the American Heart Association 13 (15) (2024)
Philip Sommer, Michael Schreinlechner, Maria Noflatscher, Clarisse Engl, Daniela Lener, Markus Theurl, Rudolf Kirchmair, Peter Marschang
Hepatocyte growth factor as indicator for subclinical atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten 53 (2) (2024)
Johannes Holfeld, Felix Naegele, Leo Pölzl, Clemens Engler, Michael Graber, Jakob Hirsch, Sophia Schmidt, Agnes Mayr, Felix Troger, Mathias Pamminger, Markus Theurl, Michael Schreinlechner, Nikolay Sappler, Elfriede Ruttmann-Ulmer, Wolfgang Schaden, John P Cooke, Hanno Ulmer, Axel Bauer, Can Gollmann-Tepeköylü, Michael Grimm
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European heart journal 45 (29) (2024)
Philip Sommer, Michael Schreinlechner, Maria Noflatscher, Clarisse Engl, Daniela Lener, Markus Theurl, Rudolf Kirchmair, Peter Marschang
Hepatocyte growth factor as indicator for subclinical atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten 53 (2) (2024)
Maria Noflatscher, Monika Hunjadi, Michael Schreinlechner, Philip Sommer, Daniela Lener, Markus Theurl, Rudolf Kirchmair, Axel Bauer, Andreas Ritsch, Peter Marschang
Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound. Biomedicines 11 (7) (2023)
Fabian Theurl, Michael Schreinlechner, Nikolay Sappler, Michael Toifl, Theresa Dolejsi, Florian Hofer, Celine Massmann, Christian Steinbring, Silvia Komarek, Kurt Mölgg, Benjamin Dejakum, Christian Böhme, Rudolf Kirchmair, Sebastian Johannes Reinstadler, Axel Bauer
Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular disease. European heart journal. Digital health 4 (3) (2023)
Michael Schreinlechner, Konstantinos D Rizas, Axel Bauer
Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE-AF. Clinical and translational medicine 13 (1) (2022)
Michael Schreinlechner, Konstantinos D Rizas, Axel Bauer
Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE-AF. Clinical and translational medicine 13 (1) (2022)
Michael Schreinlechner, Konstantinos D Rizas, Axel Bauer
Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE-AF. Clinical and translational medicine 13 (1) (2022)
Michael Schreinlechner, Fabian Theurl
Letter from Austria. Respirology (Carlton, Vic.) 27 (10) (2022)
Fabian Theurl, Nikolay Sappler, Konstantinos D Rizas, Steffen Massberg, Axel Bauer, Michael Schreinlechner
Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19. Respirology (Carlton, Vic.) 27 (9) (2022)
Michael Schreinlechner, Konstantinos D Rizas, Axel Bauer
Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE-AF. Clinical and translational medicine 13 (1) (2022)
Maria Noflatscher, Michael Schreinlechner, Philip Sommer, Philipp Deutinger, Markus Theurl, Rudolf Kirchmair, Axel Bauer, Peter Marschang
Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound. Nutrients 12 (12) (2020)

Michael Schreinlechner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Schreinlechner